Nucala multiple strengths Images

Generic Name: mepolizumab

This medication has been identified as Nucala multiple strengths. It is supplied by GlaxoSmithKline.

Nucala is used in the treatment of Chronic Rhinosinusitis With Nasal Polyps; Hypereosinophilic Syndrome; Eosinophilic Granulomatosis with Polyangiitis; Asthma, Maintenance; Asthma and belongs to the drug class interleukin inhibitors. FDA has not classified the drug for risk during pregnancy. Nucala multiple strengths is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Nucala

Generic Name

mepolizumab

Strength

multiple strengths

Availability

Prescription only

Drug Class

Interleukin inhibitors

Pregnancy Category

N - Not classified

CSA Schedule

Not a controlled drug

Labeler / Supplier

GlaxoSmithKline

National Drug Code (NDC)

multiple

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer